GlassScriptPhysician profile
Karen A Meehan
NPI 1972837037
$8,087.85
in general payments reported to CMS, 2019-2025
14 companies · $462 in 2025
The $462 reported for 2025 was more than what a typical Adult Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $186).
See the full distribution for Adult Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $424 · 2022: $1,407 · 2023: $1,808 · 2024: $3,986 · 2025: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,819 · Travel and Lodging: $2,407 · Entertainment: $30.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,819.27 |
| Travel and Lodging | $2,407.16 |
| Entertainment | $30.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,648.70 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Heartmate Touch |
| Medtronic, INC. | $2,418.98 | 2021-2025 | Hvad Pump Implant Kit |
| Abiomed | $369.78 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $151.29 | 2024-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Inspiris Resilia Aortic Valve |
| Cvrx, INC. | $134.92 | 2023 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $101.55 | 2023-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $68.21 | 2022-2023 | Farxiga, Brilinta |
| Pfizer INC. | $40.11 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $35.57 | 2023 | Verquvo |
| Argentum Medical | $30.15 | 2025 | |
| Novartis Pharmaceuticals Corporation | $25.07 | 2023 | |
| Corcept Therapeutics | $24.96 | 2025 | Korlym |
| Takeda Pharmaceuticals U.S.A., INC. | $23.33 | 2023 | Livtencity |
| Lexicon Pharmaceuticals, INC. | $15.23 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Meehan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.